AI brief of an SEC Form 8-K · Aterian, Inc. (ATER)

Aterian: Lazar sells $12 million preferred stake; no single holder gains control

Neutral Impact 4 of 5 shareholder Written later

Aterian disclosed that David E. Lazar sold his Series AA and Series AAA preferred stake to several purchasers on September 25, 2026, for an aggregate $12,000,000. After the sale Lazar holds about 3.1% of common stock, and the company says no single person or group has acquired control. The filing also reports that director Avraham Ben-Tzvi resigned and William H. Crampton joined the board, and that a $0.9936-per-CVR cash payment is due on or about October 2, 2026.

Key points

  • On September 25, 2026, Lazar sold all rights in 706,100 Series AA and 1,750,000 Series AAA preferred shares for $12,000,000 in aggregate, after the preferred converted into 241,861,970 common shares.
  • No purchaser holds more than 9.99% of fully diluted common stock, and the company says the purchasers acted independently.
  • William H. Crampton was appointed to the board on September 25, 2026, and to the Audit and Compensation Committees; Avraham Ben-Tzvi resigned effective September 25, 2026.
  • Lazar received a $150,000 retention bonus as CEO and Interim CFO, paid in two $75,000 installments; CVR holders are due approximately $0.9936 per CVR on or about October 2, 2026.

The filing

CompanyAterian, Inc. (ATER)
Form8-K, current report
Filed with the SECSep 29, 2026, 5:25 PM ET
Accession number0001437749-26-031486

Items reported: 5.01 Change in Control5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.